Optimizing treatment with anti-epidermal growth factor receptor drugs for patients with metastatic colorectal cancer: novel mechanisms of resistance beyond RAS

C. Cardone, B. Blauensteiner, V. Moreno-Viedma, M. Paul, G. Martini, T. Troiani, P. Vitiello, D. Ciardiello, L. Poliero, C. Borrelli, A. Rachiglio, D. Rizzi, E. Maiello, T. Latiano, N. Normanno, M. Sibilia, F. Ciardiello, E. Martinelli

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)iv116
JournalAnnals of oncology : official journal of the European Society for Medical Oncology
Volume30
DOIs
Publication statusPublished - Jul 1 2019

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this

Cardone, C., Blauensteiner, B., Moreno-Viedma, V., Paul, M., Martini, G., Troiani, T., Vitiello, P., Ciardiello, D., Poliero, L., Borrelli, C., Rachiglio, A., Rizzi, D., Maiello, E., Latiano, T., Normanno, N., Sibilia, M., Ciardiello, F., & Martinelli, E. (2019). Optimizing treatment with anti-epidermal growth factor receptor drugs for patients with metastatic colorectal cancer: novel mechanisms of resistance beyond RAS. Annals of oncology : official journal of the European Society for Medical Oncology, 30, iv116. https://doi.org/10.1093/annonc/mdz156.018